A Foundational Technology Development and Deployment Office to Create Jobs
Summary
The history of the United States is replete with examples of how foundational new technologies can transform the economy and create jobs. From the automobile to the transistor to recombinant DNA, foundational technologies have enabled an expanding middle class and prosperity for millions of Americans. The federal government played a vital role in providing and enabling early market development and applications for these technologies. The United States must rededicate itself to promoting new technologies beyond the research and development phase, if it is to maintain a position of global economic leadership and successful transition to the 21st century economy.
The U.S. government should create a Foundational Technology Development and Deployment Office within the Department of Commerce that retains flexible financing authority to support market-pull programs for early-stage commercialization of innovative firms. An annual $50 billion authorization, for five years, would spark nascent strategic industries (e.g., new energy production and distribution, advanced manufacturing, synthetic biology, materials, robotics, mobility, space exploration, and next-generation semiconductors), and would be critical to transitioning the U.S. workforce for the 21st century economy. With the success of such an office, the U.S. will cement itself as the global locus of frontier technology industries. The country could also ensure that the economic spillovers from innovation are distributed more equally across socio-economic groups, through the creation of more domestic, advanced manufacturing that creates middle-skill jobs.
This is a bipartisan, commonsense measure to reauthorize the Technology Modernization Fund (TMF) before it expires in September 2026.
Many states are introducing AI policies and task forces, but lack the “AI-native” personnel to build and maintain initiatives. To address this in the short term, states should establish AI Resilience Cohorts to embed early-career technologists in key offices to support state AI initiatives. Right now, Virginia and New Jersey have the opportunity to take […]
We sat down with biomedical research pioneer Lee Hood to talk moonshots, metascience in medicine, and the Human Phenome Initiative.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.